Additionally, it addresses the FDA’s communications Together with the applicant, the retention of documents that assistance the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may transfer ownership of the SE report back to a whole new applicant and Digital submission on the SE rep